Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L7a pseudogene 40 (RPL7AP40) is a pseudogene related to the ribosomal protein L7a gene. It is not believed to encode a functional protein, and has no established biological function or disease association as a pseudogene[1][4][8]. Unlike its parental gene (RPL7A), which encodes a component of the ribosomal 60S subunit, RPL7AP40 does not serve as a therapeutic target, biomarker, or drug target, and is instead classified among the multitude of processed pseudogenes arising from ribosomal protein genes in the human genome[1][4][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7a pseudogene 40 (RPL7AP40).